AI-assisted, human-published
09/02/2026 /Funding Events
NovaGo Therapeutics Completes $30 Million Series B Financing Round to Advance Nogo-A Biologics
Swiss-based NovaGo Therapeutics concludes successful financing round to progress lead program into proof-of-concept study for spinal cord injury, targeting Nogo-A protein for functional recovery.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com